subcutaneous ghk-cu clinical trial human Rejuvenation and Youth with Peptide Treatment GHK-Cu Topical vs Injection |

Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture

Research-Grade Format: High-purity, lyophilized material supports reproducible work across biochemical assays, cell culture, and animal models

Signs you should hold your current dose include nausea lasting more than three days after injection, vomiting more than once per week, inability to maintain adequate hydration, or significant disruption to daily activities

- The specific dose in milligrams and the route of administration

So, its still like, I hate to say, a dark market kind of thing or black market kind of thing, but thats kind of like what it seems like right now